Paul M. Ridker is a Preventive Cardiology affiliated with Brigham and Women's Hospital.
Paul M. Ridker's published research covers Inflammation in Atherosclerosis, C-Reactive Protein as a Biomarker, Anti-Inflammatory Therapies for Cardiovascular Disease, Statin Therapy for Primary Prevention, and Cardiovascular Risk Prediction. These are the areas where Synapse's enriched corpus most frequently indexes their work.
Paul M. Ridker is the Eugene Braunwald Professor of Medicine at Harvard Medical School and Director of the Center for Cardiovascular Disease Prevention at Brigham and Women’s Hospital in Boston, Massachusetts. He also serves as Professor of Public Health at Harvard School of Public Health. His research involves inflammatory mediators of heart disease, biomarkers for coronary disease, and the prevention of atherosclerotic disease.
Held affiliations with Brigham and Women's Hospital (2016-2025); Harvard University (2016-2025); University of Cambridge (2009-2024); Cornell University (2002-2024).
Across their career Synapse has indexed 1,409 publications, 222,853 citations, h-index 217. Enriched entries for each paper include structured clinical evidence (PICO), methodology classification with level of evidence, and guideline-recommendation linkage where applicable.
Training: BS at Brown University (1981); MD at Harvard Medical School (1986); MPH at Harvard School of Public Health (1992).
For the full publication history and per-paper clinical evidence enrichment, see this page on Synapse.
Deterministic synthesis from Synapse's enriched records — 203 words.
